Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma
- 1 November 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (4) , 853-856
- https://doi.org/10.1016/s0360-3016(99)00259-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- Prostate-specific antigen and radiation therapy for clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- PROSTATIC ACID PHOSPHATASE IN 1993Urologic Clinics of North America, 1993
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- The Value of Acid Phosphatase Measurements in Predicting Extraprostatic Cancer Growth before Radical ProstatectomyBritish Journal of Urology, 1988
- Adverse Implications of Acid Phosphatase Levels in the Upper Range of NormalJournal of Urology, 1987
- Acid Phosphatase: Its Influence on the Management of Carcinoma of the ProstateJournal of Urology, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958